Stereotactic Body Radiation Therapy (SBRT) has been utilized since the early 2000s as a minimally-invasive treatment for cancer patients, including kidney cancer. Join Dr. Sean P. Collins as he shares vital information about this disease and outlines the criteria for candidates suitable for SBRT. He discusses the factors that determine eligibility and how this treatment option can be a game-changer for those unable to undergo surgery, delivering high doses of radiation with pinpoint accuracy. Discover the unique advantages of this treatment method and how it can improve patient outcomes. For more information please visit www.tgh.org/cancer.